Cabo and colleagues explore an interesting aspect of adult kidney stone disease: financial
toxicity. This concept developed from research into the costs associated with cancer
care. Zafar and Abernathy coined the phrase in a 2013 paper, “Financial Toxicity,
Part 1: A New Name for a Growing Problem.”
1
As opposed to population-based assessments of costs, or direct expenditures associated
with care, financial toxicity is an assessment of both objective and subjective aspects
of the costs associated with treatment. A standard tool to assess this, which the
authors used, was the Comprehensive Score for Financial Toxicity (COST) calculator.
2
Available at: https://www.facit.org/measures/FACIT-COST. Accessed October 1, 2022.
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to UrologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Financial toxicity, part I: a new name for a growing problem.Oncology (Williston Park, NY). 2013; 27: 80
Available at: https://www.facit.org/measures/FACIT-COST. Accessed October 1, 2022.
Karlan D, King R, Kluender R et al. Available at: https://finhealthnetwork.org/wp-content/uploads/2022/08/Pulse-Trends-Report-2022.pdf. Accessed October 1, 2022.
- Removal of small, asymptomatic kidney stones and incidence of relapse.N Engl J Med. 2022; 387: 506-513
Article info
Identification
Copyright
© 2022 Published by Elsevier Inc.
